Brief: ReShape Announces Pricing Of Upsized $10.2 Mln Underwritten Public Offering
Feb 6 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES ANNOUNCES PRICING OF UPSIZED $10.2
MILLION
UNDERWRITTEN PUBLIC OFFERING
* ANNOUNCED PRICING OF ITS UPSIZED UNDERWRITTEN PUBLIC
OFFERING OF
1,275,000 UNITS
* EACH UNIT IS BEING SOLD AT A PUBLIC OFFERING PRICE OF
$8.00
Source text for Eikon: ID:nGNX9HTxZG
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity